Russell T. Kronengold
Keine laufenden Positionen mehr
Profil
Russell T.
Kronengold worked as Vice President-Biomaterials Research at DSM Biomedical, Inc. from 1997 to 2010.
He also worked as Chief Scientific Officer at Aperion Biologics, Inc. Additionally, he received an undergraduate degree from Carnegie Mellon University, a doctorate degree from the University of Medicine & Dentistry of New Jersey, and a graduate degree from Rutgers State University of New Jersey.
Ehemalige bekannte Positionen von Russell T. Kronengold
| Unternehmen | Position | Ende |
|---|---|---|
DSM Biomedical, Inc.
 DSM Biomedical, Inc. Medical SpecialtiesHealth Technology DSM Biomedical, Inc. manufactures and designs medical device materials. The firm's products include bioceramics, polyurethanes, device development, hydrophilic coating solutions, polyethylenes, collagen, and extracellular matrix and drug delivery materials. The company was founded by Kenneth R. Kensey and John E. Nash in 1984 and is headquartered in Exton, PA. | Corporate Officer/Principal | 15.02.2010 |
| APERION BIOLOGICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Russell T. Kronengold
| University of Medicine & Dentistry of New Jersey | Doctorate Degree |
| Rutgers State University of New Jersey | Graduate Degree |
| Carnegie Mellon University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
DSM Biomedical, Inc.
DSM Biomedical, Inc. Medical SpecialtiesHealth Technology DSM Biomedical, Inc. manufactures and designs medical device materials. The firm's products include bioceramics, polyurethanes, device development, hydrophilic coating solutions, polyethylenes, collagen, and extracellular matrix and drug delivery materials. The company was founded by Kenneth R. Kensey and John E. Nash in 1984 and is headquartered in Exton, PA. | Health Technology |
Aperion Biologics, Inc.
 Aperion Biologics, Inc. Medical DistributorsDistribution Services Aperion Biologics, Inc. engages in the development and implementation of its business plans, performing research on its platform technology, conducting clinical trials on its products in both animals and humans, pursuing regulatory approvals to market its product in U.S. and international markets, and raising capital. The firm's core platform technology is an enzymatic stripping of the key carbohydrate antigens followed by a unique conversion process that both humanizes and sterilizes the tissues without affecting their biomechanical or biological properties. The company was founded by Kevin Robert Stone in October 1996 and is headquartered in San Antonio, TX. | Distribution Services |
